122 related articles for article (PubMed ID: 7649072)
1. [Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine].
Dalery J; Bouhassira M; Kress JP; Lancrenon S; Tafani A; Hantouche EG
Encephale; 1995; 21(3):217-25. PubMed ID: 7649072
[TBL] [Abstract][Full Text] [Related]
2. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
Alpert JE; Franznick DA; Hollander SB; Fava M
J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine, placebo, and tricyclic antidepressants in major depression with and without anxious features.
Tollefson GD; Holman SL; Sayler ME; Potvin JH
J Clin Psychiatry; 1994 Feb; 55(2):50-9. PubMed ID: 8077155
[TBL] [Abstract][Full Text] [Related]
4. Is anxious-agitated major depression responsive to fluoxetine? A double-blind comparison with amitriptyline.
Marchesi C; Ceccherininelli A; Rossi A; Maggini C
Pharmacopsychiatry; 1998 Nov; 31(6):216-21. PubMed ID: 9930635
[TBL] [Abstract][Full Text] [Related]
5. [Double-blind study of mianserin and fluoxetine in ambulatory therapy of depressed patients].
Besançon G; Cousin R; Guitton B; Lavergne F
Encephale; 1993; 19(4):341-5. PubMed ID: 8275922
[TBL] [Abstract][Full Text] [Related]
6. Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms.
Davidson JR; Meoni P; Haudiquet V; Cantillon M; Hackett D
Depress Anxiety; 2002; 16(1):4-13. PubMed ID: 12203668
[TBL] [Abstract][Full Text] [Related]
7. [Paroxetine in the treatment of depression in geriatric patients--a double-blind comparative study with fluoxetine].
Schöne W; Ludwig M
Fortschr Neurol Psychiatr; 1994 Sep; 62 Suppl 1():16-8. PubMed ID: 7959520
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
[TBL] [Abstract][Full Text] [Related]
9. Deramciclane in the treatment of generalized anxiety disorder: a placebo-controlled, double-blind, dose-finding study.
Naukkarinen H; Raassina R; Penttinen J; Ahokas A; Jokinen R; Koponen H; Lepola U; Kanerva H; Lehtonen L; Pohjalainen T; Partanen A; Mäki-Ikola O; Rouru J;
Eur Neuropsychopharmacol; 2005 Dec; 15(6):617-23. PubMed ID: 15949921
[TBL] [Abstract][Full Text] [Related]
10. Fluoxetine in the treatment of anger: an open clinical trial.
Rubey RN; Johnson MR; Emmanuel N; Lydiard RB
J Clin Psychiatry; 1996 Sep; 57(9):398-401. PubMed ID: 9746447
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the efficacy and acceptability of amineptine and fluoxetine in patients with major depression].
Dalery J; Rochat C; Peyron E; Bernard G
Encephale; 1992; 18(3):257-62. PubMed ID: 1299597
[TBL] [Abstract][Full Text] [Related]
12. Comparison of efficacy and safety of milnacipran and fluoxetine in Korean patients with major depression.
Lee MS; Ham BJ; Kee BS; Kim JB; Yeon BK; Oh KS; Oh BH; Lee C; Jung HY; Chee IS; Choe BM; Paik IH
Curr Med Res Opin; 2005 Sep; 21(9):1369-75. PubMed ID: 16197655
[TBL] [Abstract][Full Text] [Related]
13. [Comparative study of paroxetine and mianserin in depression in elderly patients: efficacy, tolerance, serotonin dependence].
Daléry J; Aubin V
Encephale; 2001; 27(1):71-81. PubMed ID: 11294041
[TBL] [Abstract][Full Text] [Related]
14. [Value of tianeptine in treating major recurrent unipolar depression. Study versus placebo for 16 1/2 months of treatment].
Daléry J; Dagens-Lafant V; De Bodinat C
Encephale; 1997; 23(1):56-64. PubMed ID: 9172969
[TBL] [Abstract][Full Text] [Related]
15. Fluoxetine once every third day in the treatment of major depressive disorder.
Tural U; Onder E
Eur Arch Psychiatry Clin Neurosci; 2003 Dec; 253(6):307-12. PubMed ID: 14714120
[TBL] [Abstract][Full Text] [Related]
16. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
Rabkin JG; Rabkin R; Wagner G
J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
[TBL] [Abstract][Full Text] [Related]
17. Fluoxetine treatment of dysthymia in the elderly.
Nobler MS; Devanand DP; Kim MK; Fitzsimons LM; Singer TM; Turret N; Sackeim HA; Roose SP
J Clin Psychiatry; 1996 Jun; 57(6):254-6. PubMed ID: 8666563
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of morning versus evening fluoxetine administration.
Usher RW; Beasley CM; Bosomworth JC
J Clin Psychiatry; 1991 Mar; 52(3):134-6. PubMed ID: 2005078
[TBL] [Abstract][Full Text] [Related]
19. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
[TBL] [Abstract][Full Text] [Related]
20. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]